New Shapes – UrgoStart Plus

UrgoStart Plus Border is now available in new shapes and sizes!

Evidence-based treatment should be for every body, which is why we are pleased to announce that UrgoStart Plus Border now comes in a variety of new shapes, including 10x12cm, 13x13cm, and 17x20cm.

These new anatomical shapes are designed to fit complex body locations and make wound care easier – ensuring that every patient can be treated with a dressing that is right for them and their wound.2,3

UrgoStart Plus is suitable for patients with risk factors*, including diabetes, vascular factors, reduced mobility, older age and more.

 

*unless there is a known sensitivity or contraindication – see product leaflet for details
References:     
1. National Institute for Health and Care Excellence (NICE), UrgoStart for treating leg ulcers and diabetic foot ulcers, https://www.nice. org.uk/guidance/
mtg42, April 2023
2. URGO RID Panel tests with nurses, conducted March 2024
3. Versus standard formats, Quantitative test UrgoStart Plus border study report No.22009-2- March 2022
4. Internal in vitro study, Laboratoires Urgo
5. Münter KC, et al. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound Care.
2017;26(Suppl 2):S4–S15. doi:10.12968/jowc.2017.26.Sup2.S4
6. Edmonds M, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international,
multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018;6(3):186–96. https://doi.org/10.1016/S2213-8587(17)30492-2
7. Meaume S, et al. Evaluation of two fibrous wound dressings for the management of leg ulcers: results of a European randomised controlled trial (EARTH
RCT). J Wound Care. 2014;23(3):105–16. https://doi.org/10.12968/jowc.2014.23.3.105
8. Sigal ML, et al. Clinical evaluation of a new TLC-NOSF dressing with poly-absorbent fibers for the local management of exuding leg ulcers, at the
different stages of the healing process: Results from two multicentric, single-arm, prospective, open-label clinical trials. J Wound Care. 2019;28(3):164–75.

 

We’re Officially a Great Place to Work®!

We’re proud to announce that we’ve been accredited as a Great Place to Work®, a globally recognised certification that celebrates exceptional workplace culture.

This achievement is especially meaningful because it’s based entirely on feedback from our people.  It reflects a shared understanding of our Mission of Healing People Because We Care; care that extends not only to our patients and their caregivers, but also to our people and the planet.

 

At the heart of this recognition are our core values, which guide everything we do:

  • Learning Organisation – we continuously look for ways to learn and improve, embracing curiosity and growth.

  • Winning Mindset – we approach challenges with a ‘go above and beyond’ attitude, driven by enthusiasm and purpose.

  • Engaged Teams – we are united by our mission, working together to make a meaningful impact every day.

 

These values are underpinned by Honesty and Integrity, which are not just words, they are lived and felt by every employee across our organisation.  This accreditation confirms that our culture is one where people feel safe, supported, and inspired to be their best.

We’re proud of this milestone and remain committed to continue building on this success together, striving to be an even greater place to work, where everyone can continue to thrive and feel proud of the difference they make.